Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220782812> ?p ?o ?g. }
- W4220782812 abstract "Background: SLC1A5, a ferroptosis regulator gene, plays a dual role in cancer regulation. However, the roles of SLC1A5 in pancreatic adenocarcinoma (PAAD) remain elusive. Methods: SLC1A5's expression and somatic mutation information were determined by TCGA, GEO, Oncomine, and cBioPortal databases. Its prognostic value was assessed in TCGA cohort and was validated in three independent cohorts. The effects of SLC1A5 on the tumor immune microenvironment were analyzed by the CIBERSORT algorithm, ssGSEA method, and TISIDB and TIMER databases. The oncoPredict R package, TIDE algorithm, ImmuCellAI online tool, and GSE35141 and GSE59357 datasets were used to ascertain its therapeutic correlations. GSEA and Western blot were applied to reveal the effects of SLC1A5 on the mTORC1 signaling pathway and ferroptosis process. The biofunctions of SLC1A5 were assessed by MTT, wound-healing, Transwell, and xenograft assays. Results: SLC1A5 was significantly upregulated in the PAAD samples but was not commonly accompanied with somatic mutation (2.3%). Overexpression of SLC1A5 led to a poor prognosis and was identified as an independent prognostic factor. Moreover, high SLC1A5 expression suppressed the antitumor immune process by changing the infiltrating levels of immune cells. As for therapeutic correlations, SLC1A5 was related to the efficacy of dasatinib, sunitinib, sorafenib, and imatinib but may not predict that of radiotherapy, chemotherapeutic drugs, and immune checkpoints inhibitors (ICIs). Notably, the overexpression of SLC1A5 could activate the mTORC1 signaling pathway and may increase the cellular sensitivity to ferroptosis. Finally, the overexpression of SLC1A5 markedly promoted proliferation, migration, and invasion of pancreatic cancer cells. At the in vivo level, SLC1A5 deletion inhibited tumor growth in a mice xenograft model. Conclusions: SLC1A5 prefers to play as an accomplice rather than an opponent in PAAD. Our findings provide novel insights into PAAD treatment." @default.
- W4220782812 created "2022-04-03" @default.
- W4220782812 creator A5011935769 @default.
- W4220782812 creator A5026149938 @default.
- W4220782812 creator A5032463389 @default.
- W4220782812 creator A5035520440 @default.
- W4220782812 creator A5049117772 @default.
- W4220782812 creator A5078325945 @default.
- W4220782812 creator A5084762460 @default.
- W4220782812 creator A5089119369 @default.
- W4220782812 date "2022-03-28" @default.
- W4220782812 modified "2023-09-28" @default.
- W4220782812 title "SLC1A5 Prefers to Play as an Accomplice Rather Than an Opponent in Pancreatic Adenocarcinoma" @default.
- W4220782812 cites W1589007430 @default.
- W4220782812 cites W1969096316 @default.
- W4220782812 cites W1982203054 @default.
- W4220782812 cites W1997183854 @default.
- W4220782812 cites W2018851438 @default.
- W4220782812 cites W2101653483 @default.
- W4220782812 cites W2125673723 @default.
- W4220782812 cites W2149441684 @default.
- W4220782812 cites W2159707944 @default.
- W4220782812 cites W2214074259 @default.
- W4220782812 cites W2239158335 @default.
- W4220782812 cites W2265062179 @default.
- W4220782812 cites W2327686392 @default.
- W4220782812 cites W2527905628 @default.
- W4220782812 cites W2549428458 @default.
- W4220782812 cites W2580706718 @default.
- W4220782812 cites W2590692536 @default.
- W4220782812 cites W2593816418 @default.
- W4220782812 cites W2599354912 @default.
- W4220782812 cites W2604677166 @default.
- W4220782812 cites W2605743056 @default.
- W4220782812 cites W2613781948 @default.
- W4220782812 cites W2743246611 @default.
- W4220782812 cites W2750317630 @default.
- W4220782812 cites W2765224588 @default.
- W4220782812 cites W2792154044 @default.
- W4220782812 cites W2794021749 @default.
- W4220782812 cites W2883803263 @default.
- W4220782812 cites W2885839062 @default.
- W4220782812 cites W2886498337 @default.
- W4220782812 cites W2889646458 @default.
- W4220782812 cites W2894694766 @default.
- W4220782812 cites W2898144712 @default.
- W4220782812 cites W2902263717 @default.
- W4220782812 cites W2936903098 @default.
- W4220782812 cites W2937441321 @default.
- W4220782812 cites W2939322913 @default.
- W4220782812 cites W2942610007 @default.
- W4220782812 cites W2943793201 @default.
- W4220782812 cites W2945161487 @default.
- W4220782812 cites W2945901473 @default.
- W4220782812 cites W2948101187 @default.
- W4220782812 cites W2950764390 @default.
- W4220782812 cites W2951492084 @default.
- W4220782812 cites W2954286001 @default.
- W4220782812 cites W2968612009 @default.
- W4220782812 cites W2975961828 @default.
- W4220782812 cites W2976167782 @default.
- W4220782812 cites W3003960907 @default.
- W4220782812 cites W3005889306 @default.
- W4220782812 cites W3006048658 @default.
- W4220782812 cites W3011868091 @default.
- W4220782812 cites W3020522066 @default.
- W4220782812 cites W3025972230 @default.
- W4220782812 cites W3044225403 @default.
- W4220782812 cites W3044484601 @default.
- W4220782812 cites W3081942000 @default.
- W4220782812 cites W3090693089 @default.
- W4220782812 cites W3092336664 @default.
- W4220782812 cites W3118388357 @default.
- W4220782812 cites W3119086885 @default.
- W4220782812 cites W3119330694 @default.
- W4220782812 cites W3127932807 @default.
- W4220782812 cites W3128351562 @default.
- W4220782812 cites W3149391158 @default.
- W4220782812 cites W3174081114 @default.
- W4220782812 cites W3182293965 @default.
- W4220782812 cites W3189047529 @default.
- W4220782812 cites W3212084264 @default.
- W4220782812 doi "https://doi.org/10.3389/fcell.2022.800925" @default.
- W4220782812 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35419359" @default.
- W4220782812 hasPublicationYear "2022" @default.
- W4220782812 type Work @default.
- W4220782812 citedByCount "12" @default.
- W4220782812 countsByYear W42207828122022 @default.
- W4220782812 countsByYear W42207828122023 @default.
- W4220782812 crossrefType "journal-article" @default.
- W4220782812 hasAuthorship W4220782812A5011935769 @default.
- W4220782812 hasAuthorship W4220782812A5026149938 @default.
- W4220782812 hasAuthorship W4220782812A5032463389 @default.
- W4220782812 hasAuthorship W4220782812A5035520440 @default.
- W4220782812 hasAuthorship W4220782812A5049117772 @default.
- W4220782812 hasAuthorship W4220782812A5078325945 @default.
- W4220782812 hasAuthorship W4220782812A5084762460 @default.
- W4220782812 hasAuthorship W4220782812A5089119369 @default.
- W4220782812 hasBestOaLocation W42207828121 @default.
- W4220782812 hasConcept C104317684 @default.